Sign in
Groups
Researchers
Funding
Results
LUNGSEARCH: Lung Cancer Screening, Early Detection, Biomarkers and New Therapeutic Targets
SEARCH
Corporació Sanitària Parc Taulí
Barcelona, España
You are in
Collaborations
Corporació Sanitària Parc Taulí
Publications in collaboration with researchers from Corporació Sanitària Parc Taulí (1)
2011
Phase II study of sunitinib as first-line treatment of urothelial cancer patients ineligible to receive cisplatin-based chemotherapy: Baseline interleukin-8 and tumor contrast enhancement as potential predictive factors of activity
Annals of Oncology, Vol. 22, Núm. 12, pp. 2646-2653
Contact
Legal notice
Help
translate
en
arrow_drop_down
translate
en
arrow_drop_down
es
ca
eu
gl
fr
de